Catalytic Activity and Isoform-Specific Inhibition of Rat Cytochrome P450 4F Enzymes

Journal of Pharmacology and Experimental Therapeutics

Volumn 308, Issue 3, 2004, Pages 887-895

  Xu, Fengyun ^a   Falck, John R ^b   Ortiz De Montellano, Paul R ^a   Kroetz, Deanna L ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c Box 0446 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

10 UNDECYNYL SULFATE; 17 OCTADECYNOIC ACID; 20 HYDROXYICOSATETRAENOIC ACID; ARACHIDIC ACID; CYTOCHROME P450 4F; CYTOCHROME P450 4F1; CYTOCHROME P450 4F4; CYTOCHROME P450 4F5; CYTOCHROME P450 4F6; CYTOCHROME P450 INHIBITOR; CYTOCHROME P450 ISOENZYME; LEUKOTRIENE B4; N METHYLSULFONYL 12,12 DIBROMODODEC 11 ENAMIDE; UNCLASSIFIED DRUG;

ARACHIDONIC ACID METABOLISM; ARTICLE; BLOOD PRESSURE REGULATION; CATALYSIS; ENZYME ACTIVITY; ENZYME BINDING; ENZYME INHIBITION; ENZYME RECONSTITUTION; ENZYME SUBSTRATE; ESCHERICHIA COLI; FATTY ACID METABOLISM; HYDROXYLATION; KIDNEY TUBULE ABSORPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; ARACHIDONIC ACID; CATALYSIS; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INHIBITORS; FATTY ACIDS; HYDROXYEICOSATETRAENOIC ACIDS; HYDROXYLATION; ISOENZYMES; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS;

EID: 1342323347     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.059626     Document Type: Article

References (40)

1. Alonso-Galicia M, Maier KG, Greene AG, Cowley AW, and Roman RJ (2002) Role of 20-hydroxyeicosatetraenoic acid in the renal and vasoconstrictor actions of angiotensin II. Am J Physiol 283:R60-R68.
2. 4 ω-side chain hydroxylation by CYP4F5 and CYP4F6. Arch Biochem Biophys 412:34-41.
3. 2 20-hydroxylase of ram seminal vesicles. Arch Biochem Biophys 389:123-129.
4. Chen L and Hardwick JP (1993) Identification of a new P450 subfamily, CYP4F1, expressed in rat hepatic tumors. Arch Biochem Biophys 300:18-23.
5. Christmas P, Jones JP, Patten CJ, Rock DA, Zheng Y, Cheng SM, Weber BM, Carlesso N, Scadden DT, Rettie AE, et al. (2001) Alternative splicing determines the function of CYP4F3 by switching substrate specificity. J Biol Chem 276:38166-38172.
6. Cui X, Kawashima H, Barclay TB, Peters JM, Gonzalez FJ, Morgan ET, and Strobel HW (2001) Molecular cloning and regulation of expression of two novel mouse CYP4F genes: expression in peroxisome proliferator-activated receptor α-deficient mice upon lipopolysaccharide and clofibrate challenges. J Pharmacol Exp Ther 296:542-550.
7. Cui X, Nelson DR, and Strobel HW (2000) A novel human cytochrome P450 4F isoform (CYP4F11): cDNA cloning, expression and genomic structural characterization. Genomics 68:161-166.
8. Dawson JH and Sono M (1987) Cytochrome P-450 and chloroperoxidase: thiolate-ligated heme enzymes. Spectroscopic determination of their active-site structures and mechanistic implications of thiolate ligation. Chem Rev 87:1255-1276.
9. Dierks EA, Davis SC, and Ortiz de Montellano PR (1998) Glu-320 and Asp-323 are determinants of the CYP4A1 hydroxylation regiospecificity and resistance to inactivation by 1-aminobenzotriazole. Biochemistry 37:1839-1847.
10. Escalante B, Erlij D, Falck JR, and McGiff JC (1994) Cytochrome P-450 arachidonate metabolites affect ion fluxes in rabbit medullary thick ascending limb. Am J Physiol 266:C1775-C1782.
11. Estabrook RW, Peterson J, Baron J, and Hildebrandt A (1972) The spectrophotometric measurement of turbid suspensions of cytochromes associated with drug metabolism, in Methods in Pharmacology (Chignell CF ed) pp 303-350, Appleton-Century Crofts, New York.
12. Falck JR, Belosludtsev YY, Reddy KK, Reddy KM, Shortt MF, Chauhan K, Capdevila JH, and Wei S (1997) Eicosanoid biosynthesis: differential inhibition of cytochrome P450 epoxygenase and ω-hydroxylase. Bioorg Med Chem Lett 7:3053-3056.
13. Hashizume T, Imaoka S, Hiroi T, Terauchi Y, Fujii T, Miyazaki H, Kamataki T, and Funae Y (2001) cDNA cloning and expression of a novel cytochrome P450 (CYP4F12) from human small intestine. Biochem Biophys Res Commun 280:1135-1141.
14. Hoch U, Zhang Z, Kroetz DL, and Ortiz de Montellano PR (2000) Structural determination of the substrate specificities and regioselectivities of the rat and human fatty acid ω-hydroxylases. Arch Biochem Biophys 373:63-71.
15. Kalsotra A, Anakk S, Boehme CL, and Strobel HW (2002) Sexual dimorphism and tissue specificity in the expression of CYP4F forms in Sprague Dawley rats. Drug Metab Dispos 30:1022-1028.
16. Kawashima H, Kusunose E, Thompson CM, and Strobel HW (1997) Protein expression, characterization and regulation of CYP4F4 and CYP4F5 cloned from rat brain. Arch Biochem Biophys 347:148-154.
17. Kawashima H and Strobel HW (1995) cDNA cloning of three new forms of rat brain cytochrome P450 belonging to the CYP4F subfamily. Biochem Biophys Res Commun 217:1137-1144.
18. 4 ω-hydroxylase. J Biol Chem 268:9376-9380.
19. Kikuta Y, Kusunose E, Ito M, and Kusunose M (1999) Purification and characterization of recombinant rat hepatic CYP4F1. Arch Biochem Biophys 369:193-196.
20. Kroetz DL, Huse LM, Thuresson A, and Grillo MP (1997) Developmentally regulated expression of the CYP4A genes in the spontaneously hypertensive rat kidney. Mol Pharmacol 52:362-372.
21. Lasker JM, Chen WB, Wolf I, Bloswick BP, Wilson PD, and Powell PK (2000) Formation of 20-hydroxyeicosatetraenoic acid, a vasoactive and natriuretic eicosanoid, in human kidney. Role of CYP4F2 and CYP4A11. J Biol Chem 275:4118-4126.
22. LeBrun LA, Xu F, Kroetz DL, and Ortiz de Montellano PR (2002) Covalent attachment of the heme prosthetic group in the CYP4F cytochrome P450 family. Biochemistry 41:5931-5937.
23. Nguyen X, Wang MH, Reddy KM, Falck JR, and Schwartzman ML (1999) Kinetic profile of the rat CYP4A isoforms: arachidonic acid metabolism and isoform-specific inhibitors. Am J Physiol 276:R1691-R1700.
24. Okita RT, Clark JE, Okita JR, and Masters BS (1991) ω- and (ω-1)-hydroxylation of eicosanoids and fatty acids by high-performance liquid chromatography. Methods Enzymol 206:432-441.
25. Omura T and Sato R (1964a) The carbon monoxide-binding pigment of liver microsomes. J Biol Chem 239:2379-2385.
26. Omura T and Sato R (1964b) The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J Biol Chem 239:2370-2378.
27. +-ATPase. Nature (Lond) 314:620-622.
28. Stec DE, Deng AY, Rapp JP, and Roman RJ (1996) Cytochrome P4504A genotype cosegregates with hypertension in Dahl S rats. Hypertension 27:564-568.
29. Stec DE, Flasch A, Roman RJ, and White JA (2003) Distribution of cytochrome P-450 4A and 4F isoforms along the nephron in mice. Am J Physiol 284:F95-F102.
30. Su P, Kaushal KM, and Kroetz DL (1998) Inhibition of renal arachidonic acid ω-hydroxylase activity with ABT reduces blood pressure in the SHR. Am J Physiol 275:R426-R438.
31. 4 ω-hydroxylase as a system involving a unique cytochrome P-450 and NADPH-cytochrome P-450 reductase. Eur J Biochem 172:315-324.
32. Wang MH, Brand-Schieber E, Zand BA, Nguyen X, Falck JR, Balu N, and Schwartzman ML (1998) Cytochrome P450-derived arachidonic acid metabolism in the rat kidney: characterization of selective inhibitors. J Pharmacol Exp Ther 284:966-973.
33. Wang MH, Zhang F, Marji J, Zand BA, Nasjletti A, and Laniado-Schwartzman M (2001) CYP4A1 antisense oligonucleotide reduces mesenteric vascular reactivity and blood pressure in SHR. Am J Physiol 280:R255-R261.
34. + channel in the thick ascending limb of the rat kidney. J Gen Physiol 106:727-743.
35. Xu F, Straub WO, Pak W, Su P, Maier KG, Yu M, Roman RJ, Ortiz De Montellano PR, and Kroetz DL (2002) Antihypertensive effect of mechanism-based inhibition of renal arachidonic acid ω-hydroxylase activity. Am J Physiol 283:R710-R720.
36. Zhang X, Chen L, and Hardwick JP (2000) Promoter activity and regulation of the CYP4F2 leukotriene B4 ω-hydroxylase gene by peroxisomal proliferators and retinoic acid in HepG2 cells. Arch Biochem Biophys 378:364-376.
37. + channel in renal arterioles. Am J Physiol 270:R228-R237.
38. Zou AP, Imig JD, Kaldunski M, Ortiz de Montellano PR, Sui Z, and Roman RJ (1994a) Inhibition of renal vascular 20-HETE production impairs autoregulation of renal blood flow. Am J Physiol 266:F275-F282.
39. Zou AP, Imig JD, Ortiz de Montellano PR, Sui Z, Falck JR, and Roman RJ (1994b) Effect of P-450 ω-hydroxylase metabolites of arachidonic acid on tubuloglomerular feedback. Am J Physiol 266:F934-F941.
40. Zou AP, Ma YH, Sui ZH, Ortiz de Montellano PR, Clark JE, Masters BS, and Roman RJ (1994c) Effects of 17-octadecynoic acid, a suicide-substrate inhibitor of cytochrome P450 fatty acid ω-hydroxylase, on renal function in rats. J Pharmacol Exp Ther 268:474-481.